INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $104,000 | +4.0% | 46,103 | +57.0% | 0.00% | – |
| Q3 2021 | $100,000 | +222.6% | 29,361 | +186.9% | 0.00% | – |
| Q2 2021 | $31,000 | +210.0% | 10,234 | -2.2% | 0.00% | – |
| Q4 2019 | $10,000 | -86.8% | 10,463 | -75.2% | 0.00% | – |
| Q2 2019 | $76,000 | +153.3% | 42,114 | +117.6% | 0.00% | – |
| Q3 2016 | $30,000 | -81.0% | 19,355 | +3.6% | 0.00% | – |
| Q3 2015 | $158,000 | +22.5% | 18,674 | +59.0% | 0.00% | – |
| Q2 2015 | $129,000 | -58.5% | 11,742 | -47.3% | 0.00% | -100.0% |
| Q1 2015 | $311,000 | -16.6% | 22,279 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $373,000 | +56.1% | 22,109 | +24.0% | 0.00% | 0.0% |
| Q3 2014 | $239,000 | -15.8% | 17,830 | -19.9% | 0.00% | 0.0% |
| Q2 2014 | $284,000 | +72.1% | 22,267 | +60.4% | 0.00% | – |
| Q1 2014 | $165,000 | – | 13,886 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |